Navigation Links
DNA Genotek Launches Global Partner Program
Date:11/24/2009

Program Connects Customers with Partners Validated to Process and Analyze Samples Collected with DNA Genotek Products

Ottawa, ON (PRWEB) November 24, 2009 -- DNA Genotek, a leading provider of products for biological sample collection, stabilization and preparation, today announced its new global partner program. The program offers significant enhancements for DNA Genotek's partner community and is designed to help partners scale and differentiate themselves in the genomics market. The DNA Genotek Partner Program is open to technology vendors as well as genomics and diagnostic service providers who have demonstrated capabilities in providing services for DNA Genotek's sample collection products including Oragene®•DNA , Oragene•RNA and Oragene•ANIMAL.

The DNA Genotek Partner Program is designed to help connect customers with an approved service provider to process Oragene samples and to provide customers with confidence of compatibility with a full range of downstream processing and analysis solutions offered by multiple technology vendors.

Membership in the partner program is open to:

 
  • diagnostic service providers who accept DNA Genotek products for diagnostic tests;
  • genomics service providers and academic core facilities who offer sample management, processing and analysis; and
  • technology vendors who have either bundled DNA Genotek products into their offerings or who have validated DNA Genotek products on their platforms.

To participate in the program, potential partner companies must successfully complete validation of the DNA Genotek product(s) with their service or product offering. Upon acceptance into the program, partners will receive tools to help grow their businesses including sales and marketing resources, increased access to DNA Genotek technical staff, and closer links to researchers and clinicians seeking their services.

"Partnerships play an important part in DNA Genotek's business strategy for delivering end-to-end solutions for our customers," said Ian Curry, President and CEO, DNA Genotek, Inc. "This new program was developed in close coordination with our valued partner community. Building on our existing network of partners gives us an excellent opportunity to ensure that our customers have better access to sources for genomic analysis. Leveraging the strengths of our partners allows us to concentrate on improving sample collection while enabling our partners to extend their service offering and customer base."

A list of DNA Genotek partners can be viewed at: http://www.dnagenotek.com/DNA_Genotek_Partners_Find.html
For more information on the DNA Genotek Partner Program or to become a partner, please visit: http://www.dnagenotek.com/DNA_Genotek_Partners_Overview.html.

About DNA Genotek:

DNA Genotek focuses on providing high-quality biological sample collection, stabilization and preparation products. The company's lead product, the Oragene•DNA Self-Collection Kit, is the easiest way to collect and preserve large amounts of DNA from saliva. Oragene•DNA's reliability and ease-of-use have resulted in rapid adoption at top-tier health research institutions globally, including Harvard, Stanford, Cambridge, and Johns Hopkins. DNA Genotek markets its products worldwide and has established a global customer base in over 85 countries. For more information about DNA Genotek, visit www.dnagenotek.com

® Oragene is a registered trademark of DNA Genotek, Inc.

###

Read the full story at http://www.prweb.com/releases/2009/11/prweb3249934.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. DNA Genotek Partners with Roswell Park Cancer Institute to Accelerate Breast Cancer Research
2. DNA Genotek Sample Collection Kit Selected by Prometheus for MyCeliacID™ Genetic Test
3. DNA Genotek's Oragene●ANIMAL DNA Collection Kit Plays Key Role in Determining the Genetic Cause of Chiari Malformation in Dogs
4. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
5. Novozymes Launches Enzyme to Reduce Acrylamide in Food
6. Enova Medical Launches Exos Corporation
7. Elekta Launches New Linear Accelerator at 2007 ESTRO to Expand Cancer Treatment Availability
8. Signalifes Dr. Harmison Launches Award-Winning Ambulatory Heart Monitor
9. ThirdBiotech Networking Group Launches
10. BioReliance Launches Next-Generation Genotoxicity Screening Service
11. Midwest Research Institute Launches Center for Biological Safety and Security (CBS2)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... Diego, CA (PRWEB) , ... April 20, 2017 , ... ... management of clinical trials worldwide, announced today that they were named one of the ... , which covers the latest developments in the pharmaceutical industry. , “We take pride ...
(Date:4/20/2017)... YORK , April 20, 2017 ... that focuses on novel drug development and clinical research aimed ... are: Biostage Inc. (NASDAQ: BSTG), Keryx Biopharmaceuticals Inc. (NASDAQ: KERX), ... ZIOP ). You can access our complimentary research ... ...
(Date:4/19/2017)... ... 2017 , ... Optofluidics today announced that it's changing its ... changed focus to making analytical tools for biopharmaceutical quality control. “We are excited ... Robert Hart. Founders Bernardo Cordovez, Robert Hart and David Erickson have steered the ...
(Date:4/19/2017)... , ... April 19, 2017 , ... ... which makes educational webinars accessible to novices as well as experienced users, ... variables of commonly performed coagulation screening tests. , Hemostasis testing quality is ...
Breaking Biology Technology:
(Date:4/13/2017)... April 13, 2017 According to a new market ... Identity Analytics, Identity Administration, and Authorization), Service, Authentication Type, Deployment Mode, Vertical, ... Market is expected to grow from USD 14.30 Billion in 2017 to ... of 17.3%. ... MarketsandMarkets Logo ...
(Date:4/6/2017)... 2017 Forecasts by Product Type ... by End-Use (Transportation & Logistics, Government & Public Sector, ... Fossil Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation ... Are you looking for a definitive report on the ... ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
Breaking Biology News(10 mins):